Skip to main content

Newsroom press releases

09/11/17 - 14:15

GROWTH IN REVENUES AND NET PROFIT IN Q3 2017. STRONG FREE CASH FLOW GENERATION. 2017 GUIDANCE CONFIRMED (1001.87 KB)
Financial Data

29/09/17 - 15:00

DiaSorin revises its guidance upwards for 2019 as a consequence of the completion of the acquisition of ELISA immunodiagnostic business portfolio and associated assets from SIEMENS (928.39 KB)
Financial Data

03/08/17 - 14:45

DiaSorin Group reports strong growth in revenues and profitability in Q2 2017 (1015.93 KB)
Financial Data

26/06/17 - 9:45

DiaSorin presents its 2017-2019 Industrial Plan (479.98 KB)
Financial Data

08/05/17 - 19:30

DiaSorin Group reports growth in revenues and profitability in the first quarter 2017, generating a relevant cash flow (984.86 KB)
Financial Data

27/04/17 - 18:45

DiaSorin - Annual General Meeting 2016 (421.04 KB)
Financial Data

08/03/17 - 15:30

The Board of Directors approves the results for FY'16 (1.13 MB)
Financial Data

08/11/13 - 1:00

The Board of Directors approves the Q3'13 Results (766.57 KB)
Financial Data

01/08/13 - 2:00

The Board of Directors approves the results for the H1 '13 (386.67 KB)
Financial Data

10/05/13 - 2:00

The Board of Directors approves the results for Q1'13 (763.61 KB)
Financial Data

02/05/13 - 2:00

Compensation Commitee-Errata corrige (179.38 KB)
Financial Data

22/04/13 - 2:00

Shareholders' meeting approves FY Results 2012 (57.22 KB)
Financial Data

08/03/13 - 1:00

The BoD approves FY 2012 results (477.24 KB)
Financial Data

07/03/13 - 1:00

Notification of changes in share capital (46.86 KB)
Financial Data

07/03/13 - 1:00

Notice availability By-Laws (36.87 KB)
Financial Data

07/02/13 - 1:00

Notification of changes in share capital (46.89 KB)
Financial Data

07/02/13 - 1:00

Notice availability By-Laws (139.13 KB)
Financial Data

30/01/13 - 1:00

The Board of Directors approves the results for the FY '12 (477.24 KB)
Financial Data